OUTCOMES OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) IN GREECE UNDER RANIBIZUMAB

被引：0
|
作者：
Yfantopoulos, J. [1 ]
Rouvas, A. [2 ]
Chatzaras, A. [1 ]
Xanthopoulou, P. [2 ]
Theodosiadis, P. [2 ]
机构：
[1] Univ Athens, Athens 11528, Greece
[2] Attikon Univ Hosp Athens, Chaidari, Greece
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2102
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS4
引用
收藏
页码：A604 / A604
页数：1
相关论文
共 50 条
  • [1] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [2] Ranibizumab for neovascular age-related macular degeneration
    Hernandez-Pastor, Luis Javier
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (19) : 1805 - 1814
  • [3] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [4] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [5] Ranibizumab: treatment in patients with neovascular age-related macular degeneration
    Pieramici, Dante J.
    Avery, Robert L.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (11) : 1237 - 1245
  • [6] Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration
    Cohen, Salomon Yves
    Maloberti, Bertrand
    Fajnkuchen, Franck
    Nghiem-Buffet, Sylvia
    Delahaye-Mazza, Corinne
    Grenet, Typhaine
    Quentel, Gabriel
    [J]. OPHTHALMOLOGICA, 2014, 231 (02) : 80 - 85
  • [7] Ranibizumab for neovascular age-related macular degeneration - Reply
    Rosenfeld, Philip J.
    Brown, David M.
    Schneider, Susan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 749 - 750
  • [8] Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab
    Hsu, Jason
    Obeid, Anthony
    Mellen, Phoebe L.
    Wibbelsman, Turner D.
    Konkoly, Michelle A.
    Velez, Michael R.
    Calem, Daniel B.
    Sioufi, Kareem
    Su, Daniel
    Storey, Philip
    Klufas, Michael A.
    Spirn, Marc J.
    Regillo, Carl
    Ho, Allen C.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [9] Six-year outcomes in neovascular age-related macular degeneration with ranibizumab
    Jacob, Julie
    Brie, Heidi
    Leys, Anita
    Levecq, Laurent
    Mergaerts, Filip
    Denhaerynck, Kris
    Vancayzeele, Stefaan
    Van Craeyveld, Eline
    Abraham, Ivo
    MacDonald, Karen
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (01) : 81 - 90
  • [10] Two Year Real World Outcomes of Ranibizumab Therapy for Neovascular Age Related Macular Degeneration (nAMD)
    Bhalla, Minak
    Muniraju, Ramu
    [J]. OPHTHALMOLOGICA, 2014, 232 : 4 - 4
12345